VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma.

Inactivation of the tumor suppressor von Hippel-Lindau (VHL) gene is a key event in hereditary and sporadic clear cell renal cell carcinomas (ccRCC). The mechanistic target of rapamycin (mTOR) signaling pathway is a fundamental regulator of cell growth and proliferation, and hyperactivation of mTOR signaling is a common finding in ...
VHL-dependent ccRCC. Deregulation of mTOR signaling correlates with tumor progression and poor outcome in patients with ccRCC. Here, we report that the regulatory-associated protein of mTOR (RAPTOR) is strikingly repressed by VHL. VHL interacts with RAPTOR and increases RAPTOR degradation by ubiquitination, thereby inhibiting mTORC1 signaling. Consistent with hyperactivation of mTORC1 signaling in VHL-deficient ccRCC, we observed that loss of vhl-1 function in C. elegans increased mTORC1 activity, supporting an evolutionary conserved mechanism. Our work reveals important new mechanistic insight into deregulation of mTORC1 signaling in ccRCC and links VHL directly to the control of RAPTOR/mTORC1. This may represent a novel mechanism whereby loss of VHL affects organ integrity and tumor behavior.
Mesh Terms:
Animals, Caenorhabditis elegans, Carcinoma, Renal Cell, Cell Growth Processes, Cell Proliferation, Gene Expression Regulation, Neoplastic, HEK293 Cells, Humans, Kidney Neoplasms, Mechanistic Target of Rapamycin Complex 1, Regulatory-Associated Protein of mTOR, Signal Transduction, Ubiquitination, Von Hippel-Lindau Tumor Suppressor Protein
Sci Rep
Date: Dec. 21, 2020
Download Curated Data For This Publication
233713
Switch View:
  • Interactions 3